Cece Calhoun

Dr. Cece Calhoun is an Assistant Professor of Medicine (Hematology) at Yale University School of Medicine, specializing in Sickle Cell Disease (SCD). She serves as Medical Director of the Adult Sickle Cell Program at Smilow Cancer Hospital and Associate Chief of Operations at Smilow. Her research focuses on healthcare transitions for adolescents with SCD, implementation science, and health equity. She holds an MBA from Yale SOM, MPHS from Washington University, and completed clinical and leadership training at NIH and American Society of Hematology.

Education: MD from Wayne State University, BA in Afro American Studies from University of Michigan. Leadership roles include NIH-funded investigator and collaborations nationwide. Awards include Top Health Professionals Under Forty (2022) and Guardian of Childhood (2021).

Research emphasizes curative therapies, pain management, and SCD disparities. Recent publications address gene therapy cost-effectiveness, buprenorphine use in providers, and resilience in child-caregiver dyads. Active in clinical trials (e.g., RelatIVITY-069 for lymphoma) and serves on editorial/review boards including Blood Advances and Journal of Clinical Medicine.